bioRxivNeurosciencePreprint
Reactive Astrocytes Drive Extracellular Acidification to Mediate α-Synuclein Neurodegeneration
Jae‐Jin SongiD, Hyejin ParkiD, YuRee Choi, Taekyung RyuiD, Jisu ShiniD, Seo-Hyun KimiD, Albert Park, Justin WangiD, Devanik BiswasiD, Shih-Ching Chou, Shinwon Ha, Yura JangiD, Yu Jung ShiniD, Hao Wen CheniD, Ingie HongiD, John A. WemmieiD, Per SvenningssoniD, Juan Carlos TroncosoiD, Jiadi XuiD, C. Na, Valina Lynn DawsoniD, Ted M. DawsoniD, Tae‐In KamiD
Abstract
Astrocytes are increasingly recognized as key players in neurodegeneration1-3, yet the molecular mechanisms by which they drive disease remain elusive. Here, we uncover a fundamental pathway in which reactive astrocytes fuel neurodegeneration in -synucleinopathies--including Dementia with Lewy bodies and Parkinsons disease dementia--by acidifying the brains extracellular environment. We demonstrate that both human patient tissue and a gut-to-brain -synuclein mouse model exhibit accumulation of reactive astrocytes and extracellular acidosis. Mechanistically, we show that astrocytic lysosomal exocytosis releases acidic contents, driving a drop in pH that activates neuronal acid-sensing ion channel 1a (ASIC1a), resulting in neuronal loss and behavioral decline. Blocking this pathway--either by inhibiting astrocytic lysosomal exocytosis or genetically or pharmacologically targeting neuronal ASIC1a--mitigates pathology and rescues neurodegenerative phenotypes in vivo. These findings provide a conceptual advance by establishing a mechanistic link between glial inflammation, acid-base homeostasis, and neuronal vulnerability, and suggest that targeting astrocyte-driven acidification or ASIC1a signaling could offer new avenues for disease modification in -synucleinopathies.
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Astrocytic ACSBG1 depletion improves lipid-cytokine signaling and attenuates α-Synuclein pathology in a Parkinson's disease mouse model
Young Doo Kim, Bhupesh Vaidya, … Huda Yahya Zoghbi·bioRxiv·Jun 8, 2026
- Octopamine metabolically reprograms astrocytes to confer neuroprotection against α-synuclein
Andrew K. Shum, Sofia Zaichick, … Gabriela Caraveo·Proceedings of the National Academy of SciencesPeer-reviewed·Apr 17, 2023
- Presynaptic accumulation of α-synuclein causes synaptopathy and progressive neurodegeneration
Jéssika Cristina Bridi, Erika Bereczki, … Frank Hirth·Brain CommunicationsPeer-reviewed·Mar 19, 2021
- Lysosomal Exocytosis Releases Pathogenic α-Synuclein Species from Neurons
Y. Xue Xie, N. N. Naseri, … M. Sharma·bioRxiv·Apr 10, 2021
- Microglia Clear Neuron-released α-Synuclein via Selective Autophagy and Prevent Neurodegeneration
Insup Choi, Yuanxi Zhang, … Zhenyu Yue·Nature CommunicationsPeer-reviewed·Mar 13, 2020
- Astrocytic Cathepsin D truncates α-synuclein and promotes Lewy neurite-like aggregation in neurons
Hiroshi Hanafusa, Kota Ohashi, … Kunihiro Matsumoto·bioRxiv·Oct 3, 2025